Anna Berkenblit Net Worth
The Estimated Net Worth of Anna Berkenblit Is at Least $5.4 Million Dollars as of 24 February 2020. Ms. Berkenblit Owns over 25,803 Units of Immunogen Stock...
The estimated Net Worth of Anna Berkenblit is at least $5.4 Million dollars as of 24 February 2020. Ms. Berkenblit owns over 25,803 units of Immunogen stock worth over $3,064,300 and over the last 7 years she sold IMGN stock worth over $522,702. In addition, she makes $1,808,700 as Senior Vice President and Chief Medical Officer at Immunogen.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Berkenblit IMGN stock SEC Form 4 insiders trading
Anna has made over 6 trades of the Immunogen stock since 2017, according to the Form 4 filled with the SEC. Most recently she sold 25,803 units of IMGN stock worth $128,757 on 24 February 2020.
The largest trade she's ever made was selling 25,803 units of Immunogen stock on 24 February 2020 worth over $128,757. On average, Anna trades about 3,169 units every 39 days since 2017. As of 24 February 2020 she still owns at least 98,089 units of Immunogen stock.
You can see the complete history of Ms. Berkenblit stock trades at the bottom of the page.
Sophia analyzes international trade, startup ecosystems, retail transformation, and supply chain logistics for modern digital publications.
